4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-021387
Chief Medical Officer acquired 950,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2022-03-24 | Grant or award | +950,000 | 4,118,757 | D | ||
| Derivatives | |||||||
| Karlin Dan Chief Medical Officer | 2022-03-24 | Grant or award · Stock Option (Right to Buy) | +1,250,000 | 2,719,000 | D | ||
Loading xslF345X03/doc4.xml…